Nature Communications 2: Article number: 338 (2011); Published: 7 June 2012; Updated: 25 September 2012.

This Article contains errors in the numbering of several papers in the reference list; reference 34 is incorrectly listed as reference 44 and references 35 to 44 are incorrectly listed as 34 to 43. The correct numbering is as follows.

34.Cadieux, C. et al. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types. Cancer Res. 69, 7188–7197 (2009).

35.Kedinger, V. et al. p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin. J. Biol. Chem. 284, 27701–27711 (2009).

36.Michl, P. et al. CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7, 521–532 (2005).

37.Aleksic, T. et al. CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation. Oncogene 26, 5939–5949 (2007).

38.Kunath, T. et al. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat. Biotechnol. 21, 559–561 (2003).

39.Shouval, D. et al. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA. Cancer Res. 41, 1342–1350 (1981).

40.Nomura, F., Ohnishi, K. & Tanabe, Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 64, 1700–1707 (1989).

41.Johnson, P., Melia, W., Palmer, M., Portmann, B. & Williams, R. Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma. Br. J. Cancer 44, 502–505 (1981).

42.Xu, H. et al. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 52, 1431–1442 (2010).

43.Ledford, A. W. et al. Deregulated expression of the homeobox gene Cux-1 in transgenic mice results in downregulation of p27(kip1) expression during nephrogenesis, glomerular abnormalities, and multiorgan hyperplasia. Dev. Biol. 245, 157–171 (2002).

44.Brantley, J. G., Sharma, M., Alcalay, N. I. & Heuvel, G. B. Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis. Kidney Int. 63, 1240–1248 (2003).